Contact:
Tel: +49 (0) 214 87 63 20
Email: ir@biofrontera.com
Web: www.biofrontera.com
(C) 2024 Electronic News Publishing, source
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 EUR | -2.46% |
|
-2.14% | -64.73% |
06-24 | Biofrontera Announces the Launch of A New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp | CI |
05-31 | Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Contact:
Tel: +49 (0) 214 87 63 20
Email: ir@biofrontera.com
Web: www.biofrontera.com
(C) 2024 Electronic News Publishing, source
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2.97 EUR | -2.46% | -2.14% | 19.44M | ||
0.9 USD | -1.10% | -12.62% | 4.63M | ||
1st Jan change | Capi. | |
---|---|---|
-64.73% | 19.44M | |
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B |